{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:26:09Z","timestamp":1760189169046},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[1994,1,1]],"date-time":"1994-01-01T00:00:00Z","timestamp":757382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion Medicine Reviews"],"published-print":{"date-parts":[[1994,1]]},"DOI":"10.1016\/s0887-7963(94)70094-8","type":"journal-article","created":{"date-parts":[[2010,12,18]],"date-time":"2010-12-18T09:29:08Z","timestamp":1292664548000},"page":"15-28","source":"Crossref","is-referenced-by-count":41,"title":["The Efficacy of Leukodepletion to Improve Platelet Transfusion Response: A Critical Appraisal of Clinical Studies"],"prefix":"10.1016","volume":"8","author":[{"given":"Nancy M.","family":"Heddle","sequence":"first","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0887-7963(94)70094-8_bib1","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1056\/NEJM196911272812202","article-title":"Platelet transfusion therapy The selection of compatible platelet donors for refractory patients by lymphocyte HL-A typing","volume":"281","author":"Yankee","year":"1969","journal-title":"N Engl J Med"},{"key":"10.1016\/S0887-7963(94)70094-8_bib2","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1182\/blood.V52.4.846.846","article-title":"HLA-matched platelet transfusion therapy of severe aplastic anemia","volume":"52","author":"Tosato","year":"1978","journal-title":"Blood"},{"key":"10.1016\/S0887-7963(94)70094-8_bib3","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1182\/blood.V51.5.781.781","article-title":"Platelet transfusion therapy. Optimal donor selection with a combination of lymphocytotoxicity and platelet fluorescence tests","volume":"51","author":"Brand","year":"1987","journal-title":"Blood"},{"key":"10.1016\/S0887-7963(94)70094-8_bib4","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1182\/blood.V46.5.743.743","article-title":"Correction of poor platelet transfusion responses with leukocyte-poor HLA-matched platelet concentrates","volume":"46","author":"Herzig","year":"1975","journal-title":"Blood"},{"key":"10.1016\/S0887-7963(94)70094-8_bib5","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/ajh.2830020303","article-title":"Successful transfusion of platelets \u201cmismatched\u201d for HLA antigens to a1loimmunized thrombocytopenic patients","volume":"2","author":"Duquesnoy","year":"1977","journal-title":"Am J Hematol"},{"key":"10.1016\/S0887-7963(94)70094-8_bib6","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1046\/j.1537-2995.1983.23483276859.x","article-title":"Potential HLA-matched platelet donor availability for alloimmunized patients","volume":"23","author":"Schiffer","year":"1983","journal-title":"Transfusion"},{"key":"10.1016\/S0887-7963(94)70094-8_bib7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1365-2141.1981.00059.x","article-title":"A crossmatching procedure for the selection of platelet donors for alloimmunized patients","volume":"48","author":"Waters","year":"1981","journal-title":"Br J Haematol"},{"key":"10.1016\/S0887-7963(94)70094-8_bib8","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1046\/j.1537-2995.1977.17678075665.x","article-title":"Selection of compatible platelet donors: A prospective evaluation of three crossmatching techniques","volume":"17","author":"Wu","year":"1977","journal-title":"Transfusion"},{"key":"10.1016\/S0887-7963(94)70094-8_bib9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1365-2141.1984.tb01267.x","article-title":"Prospective platelet crossmatching for selection of compatible random donors","volume":"56","author":"Freedman","year":"1984","journal-title":"Br J Haematol"},{"key":"10.1016\/S0887-7963(94)70094-8_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ajh.2830280102","article-title":"Random donor platelet crossmatching: Comparison of four platelet antibody detection methods","volume":"28","author":"Freedman","year":"1988","journal-title":"Am J Hematol"},{"key":"10.1016\/S0887-7963(94)70094-8_bib11","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1046\/j.1537-2995.1985.25485273823.x","article-title":"The predictive value of crossmatching platelet transfusion for alloimmunized patients","volume":"25","author":"Kickler","year":"1985","journal-title":"Transfusion"},{"key":"10.1016\/S0887-7963(94)70094-8_bib12","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/ajcp\/90.1.63","article-title":"Use of a solid phase red cell adherence method for pretransfusion platelet compatibility testing","volume":"90","author":"Rachel","year":"1988","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/S0887-7963(94)70094-8_bib13","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1182\/blood.V75.1.313.313","article-title":"A randomized, placebo-controlled trial of intravenous gammaglobulin in a1loimmunized thrombocytopenic patients","volume":"75","author":"Kickler","year":"1990","journal-title":"Blood"},{"key":"10.1016\/S0887-7963(94)70094-8_bib14","unstructured":"Heddle NM, Kelton lG, Meyer R, et al: A RCT to deterrnine the effectiveness of RE blockade by RhIg on platelet response in acute leukemia (manuscript in preparation)"},{"key":"10.1016\/S0887-7963(94)70094-8_bib15","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0140-6736(81)92626-X","article-title":"Delayed a1loimmunisation by random single donor platelet transfusions. A randomised study to compare single donor and multiple donor platelet transfusions in cancer patients with severe thrombocytopenia","volume":"1","author":"Sintnicolaas","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/S0887-7963(94)70094-8_bib16","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1182\/blood.V62.2.473.473","article-title":"Delayed alloimmunization using random single donor platelet transfusions: A prospective study in thrombocytopenic patients with acute leukemia","volume":"62","author":"Gm\u00fcr","year":"1983","journal-title":"Blood"},{"key":"10.1016\/S0887-7963(94)70094-8_bib17","unstructured":"Singer J, Ali A, Warkentin TE, et al: The Hamilton Leukemia Management Group. A randomized trial of randomdonor platelets in HLA-matched platelet transfusion in adult patients with acute leukemia (manuscript in preparation)"},{"key":"10.1016\/S0887-7963(94)70094-8_bib18","first-page":"84","article-title":"Alloimmunization against the MHC antigens after platelet transfusions is due to contaminating leukocytes in the platelet suspension","volume":"9","author":"Claas","year":"1981","journal-title":"Exp Hematol"},{"key":"10.1016\/S0887-7963(94)70094-8_bib19","first-page":"77","article-title":"Prevention of platelet refractoriness due to HLA antibodies by administration of leukocytepoor blood components","volume":"9","author":"Eernisse","year":"1981","journal-title":"Exp Hematol"},{"key":"10.1016\/S0887-7963(94)70094-8_bib20","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1182\/blood.V62.4.815.815","article-title":"A randomized trial of leukocyte-depleted platelet transfusion to modify alloimmunization in patients with leukemia","volume":"62","author":"Schiffer","year":"1983","journal-title":"Blood"},{"key":"10.1016\/S0887-7963(94)70094-8_bib21","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1365-2141.1986.tb02965.x","article-title":"Use of leucocyte- poor blood components and HLA-matched-platelet donors to prevent HLA alloimrnunization","volume":"62","author":"Murphy","year":"1986","journal-title":"Br J Haematol"},{"key":"10.1016\/S0887-7963(94)70094-8_bib22","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1182\/blood.V72.3.964.bloodjournal723964","article-title":"Prevention of HLA immunization with leukocyte-poor packed red cells and platelet concentrates obtained by fi\u0142tration","volume":"72","author":"Andreu","year":"1988","journal-title":"Blood"},{"key":"10.1016\/S0887-7963(94)70094-8_bib23","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1182\/blood.V71.5.1402.1402","article-title":"Prevention of refractoriness and HLA-alloimmunization using filtered blood products","volume":"71","author":"Sniecinski","year":"1988","journal-title":"Blood"},{"key":"10.1016\/S0887-7963(94)70094-8_bib24","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1182\/blood.V75.2.512.512","article-title":"Effective prophylaxis against platelet refractoriness in multitransfused patients by use of leukocyte-free blood components","volume":"75","author":"Saarinen","year":"1990","journal-title":"Blood"},{"key":"10.1016\/S0887-7963(94)70094-8_bib25","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1046\/j.1537-2995.1991.31791368333.x","article-title":"Prevention of alloimmunization in patients with acute leukemia by use of white cell-reduced blood components\u2014A randomized trial","volume":"31","author":"Oksanen","year":"1991","journal-title":"Transfusion"},{"key":"10.1016\/S0887-7963(94)70094-8_bib26","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1182\/blood.V77.1.201.201","article-title":"Use of leukocyte-depleted platelet concentrates for the prevention of refractoriness and primary HLA alloimmunization: A prospective, randomized trial","volume":"77","author":"van Marwijk Kooy","year":"1991","journal-title":"Blood"},{"key":"10.1016\/S0887-7963(94)70094-8_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V79.5.1371.1371","article-title":"An animal model of a1logeneic donor platelet refractoriness: The effect of the time of leukodepletion","volume":"79","author":"Blajchman","year":"1992","journal-title":"Blood"},{"key":"10.1016\/S0887-7963(94)70094-8_bib28","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1046\/j.1537-2995.1989.29589284133.x","article-title":"UV-irradiated platelets: Ready to use?","volume":"29","author":"Brand","year":"1989","journal-title":"Transfusion"},{"key":"10.1016\/S0887-7963(94)70094-8_bib29","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1046\/j.1537-2995.1989.29589284148.x","article-title":"Transfusions with a tan. Prevention of a1losensitization by ultraviolet irradiation","volume":"29","author":"Deeg","year":"1989","journal-title":"Transfusion"},{"key":"10.1016\/S0887-7963(94)70094-8_bib30","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1182\/blood.V69.2.414.414","article-title":"Prevention of platelet alloimmunization in dogs with systemic cyclosporine and by UV-irradiation or cyclosporine-Loading of donor platelets","volume":"69","author":"Slichter","year":"1987","journal-title":"Blood"},{"key":"10.1016\/S0887-7963(94)70094-8_bib31","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0887-7963(89)70078-X","article-title":"Transfusion-induced alloimmunization and immunosuppression and the effects of ieukocyte depletion","volume":"3","author":"Meryman","year":"1989","journal-title":"Transfus Med Rev"},{"key":"10.1016\/S0887-7963(94)70094-8_bib32","series-title":"A Basic Science for Clinical Medicine","article-title":"C1inical Epidemiology","author":"Sackett","year":"1985"},{"key":"10.1016\/S0887-7963(94)70094-8_bib33","unstructured":"Guyatt GH, Sackett DL, Cook OJ: Evidence-based medicine working group. Evidence-based medicine: User's guide to the medical literature. II. How to use an article about therapy or prevention. Part A. Are the results of the study valid? JAMA (in press)"},{"key":"10.1016\/S0887-7963(94)70094-8_bib34","unstructured":"Guyatt GH, Sackett DL, Cook DJ: Evidence-based medicine working group. Evidence-based medicine: User's guide to the medical literature. II. How to use an article about therapy or prevention. Part B. What are the results and will they help me in caring for my patients? JAMA (in press)"},{"key":"10.1016\/S0887-7963(94)70094-8_bib35","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1046\/j.1537-2995.1991.31591263191.x","article-title":"Factors influencing 20-hour increments after platelet transfusion","volume":"31","author":"Bishop","year":"1991","journal-title":"Transfusion"},{"key":"10.1016\/S0887-7963(94)70094-8_bib36","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1365-2141.1989.tb07757.x","article-title":"Factors influencing the transfusion response to HLA-selected apheresis platelets in patients refractory to random platelet concentrates","volume":"73","author":"McFarland","year":"1989","journal-title":"Br J Haematol"},{"key":"10.1016\/S0887-7963(94)70094-8_bib37","unstructured":"Heddle NM: Leukodepletion of blood products to improve platelet transfusion response. MSc Thesis (DME Program), McMaster University, Hamilton, Canada, 1992"}],"container-title":["Transfusion Medicine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887796394700948?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887796394700948?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,14]],"date-time":"2020-06-14T20:59:09Z","timestamp":1592168349000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887796394700948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1994,1]]}},"alternative-id":["S0887796394700948"],"URL":"https:\/\/doi.org\/10.1016\/s0887-7963(94)70094-8","relation":{},"ISSN":["0887-7963"],"issn-type":[{"value":"0887-7963","type":"print"}],"subject":[],"published":{"date-parts":[[1994,1]]}}}